Back to Schemes

Sponsored

cfDNA Extraction from Plasma (Round 2)

Supported by

AstraZeneca

Product Code: 06-CFDNA-RD2-27

Free

Deadline to order: 28/02/2027

EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in Sept 2027. This EQA is sponsored.

Target/Genes:

 Quality and quantity of cfDNA extracted from plasma

Technology:

DNA extraction

Language:

English

Sample Type:

Plasma (cfDNA)

Accredited:

No

Sample dispatch to your laboratory:

Sep-27

Test and Submit Results:

September - October 2027

Final Results and Certificate:

 February 2028

You can complete purchase on our secure partner site.

How it works

Register

  • Enrol before the closing date (28/02/2027)
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via your website account (September - October 2027)

Review & get certified

  • EMQN assesses your data
  • Receive your individual results, EQA summary report & certificate of participation ( February 2028)

EQA Assessment

The scheme is designed to assess the pre-analytical process for extraction of cfDNA.

Participants will receive an individual report including educational advice and a scheme summary report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics which allow participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Sample Details

Three artificial plasma samples (4ml) designed to mimic patient samples will be provided for cfDNA extraction. 

EQA Results

Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Participation Information

Participants are expected to extract cfDNA from the samples according to their routine strategy. Participants are responsible for returning the extracted cfDNA in tubes and packaging provided by EMQN and must complete the data collection form.

This EQA is supported by an educational grant from AstraZeneca, fees are subsidised so there is a no cost for participants. EMQN would like to acknowledge and thank AstraZeneca for this support.

Participation is limited, please register early to avoid disappointment. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.